Decoding the evolution of preventive chemotherapy schemes for schistosomiasis in China to improve the precise implementation of the WHO guideline on control and elimination of human schistosomiasis.
10.16250/j.32.1374.2022111
- Author:
Jing XU
1
;
Yi Feng LI
2
;
Yi DONG
3
;
Zheng Yuan ZHAO
4
;
Li Yong WEN
5
;
Shi Qing ZHANG
6
;
Dan Dan LIN
2
;
Jie ZHOU
4
;
Song LIANG
7
;
Jia Gang GUO
8
;
Shi Zhu LI
1
;
Xiao Nong ZHOU
1
Author Information
1. National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Health Committee Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China.
2. Jiangxi Provincial Institute of Parasitic Diseases, China.
3. Yunnan Provincial Institute of Endemic Diseases, China.
4. Hunan Provincial Institute of Schistosomiasis Control, China.
5. Hangzhou Medical College, Zhejiang Center for Schistosomiasis Control, China.
6. Anhui Provincial Institute of Schistosomiasis Control, China.
7. University of Florida, USA.
8. Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.
- Publication Type:Review
- Keywords:
Elimination;
Guideline;
Praziquantel;
Preventive chemotherapy;
Schistosomiasis
- MeSH:
China/epidemiology*;
Humans;
Prevalence;
Public Health;
Schistosomiasis/prevention & control*;
World Health Organization
- From:
Chinese Journal of Schistosomiasis Control
2022;34(3):223-229
- CountryChina
- Language:Chinese
-
Abstract:
Preventive chemotherapy is one of the pivotal interventions for the control and elimination of schistosomiasis, which is effective to reduce the morbidity and prevalence of schistosomiasis. In order to promote the United Nations' sustainable development goals and the targets set for schistosomiasis control in the Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021-2030, WHO released the guideline on control and elimination of human schistosomiasis in 2022, with major evidence-based updates of the current preventive chemotherapy strategy for schistosomiasis. In China where great success has been achieved in schistosomiasis control, the preventive chemotherapy strategy for schistosomiasis has been updated several times during the past seven decades. This article reviews the evolution of the WHO guidelines on preventive chemotherapy and Chinese national preventive chemotherapy schemes, compares the current Chinese national preventive chemotherapy scheme and the recommendations for preventive chemotherapy proposed in the 2022 WHO guideline on control and elimination of human schistosomiasis, and proposes recommendations for preventive chemotherapy during the future implementation of the 2022 WHO guideline, so as to provide insights into schistosomiasis control among public health professionals engaging in healthcare foreign aid.
